RxDoctor Payments Data

Jack Brunson, MD

Family Medicine · Greer, SCNPI 1316918253

Payments from drug & device makers

$5,796in general payments, 2019–2025

Across 307 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$813
  • Johnson & Johnson$287
  • Lilly USA, LLC$212
  • Pfizer$183
  • plus $720 from 12 others

What the payments were for

  • Food & beverage$5,796100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,796 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$88,405
Medicare patients
145
Services billed
1,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$83,829
OxycontinOxycodone Hcl27$62,064
FarxigaDapagliflozin Propanediol40$56,560
JardianceEmpagliflozin42$49,147
XareltoRivaroxaban33$35,104
Repatha SureclickEvolocumab27$33,860
Albendazole12$33,023
VraylarCariprazine Hcl20$28,397
EliquisApixaban18$23,428
QuliptaAtogepant13$13,973
TrintellixVortioxetine Hydrobromide18$11,889
LinzessLinaclotide18$9,694
VyvanseLisdexamfetamine Dimesylate25$9,577
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine130$4,932
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen136$4,332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$813$83,82954 claims
AstraZenecaFarxiga, Symbicort$1,103$59,44251 claims
AbbVieVraylar, Qulipta, Linzess, Synthroid$2,478$53,16262 claims
Johnson & JohnsonXarelto$287$35,10433 claims
PfizerEliquis$183$23,42818 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$32$21,46743 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Greer

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →